Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 7
1998 2
2000 1
2001 2
2002 3
2003 3
2004 3
2005 3
2006 2
2007 1
2009 1
2010 4
2011 2
2012 4
2013 3
2014 10
2015 5
2016 4
2017 12
2018 14
2019 17
2020 14
2021 16
2022 16
2023 11
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Results by year

Filters applied: . Clear all
Page 1
Inflammatory myopathies: an update for neurologists.
Silva AMS, Campos ED, Zanoteli E. Silva AMS, et al. Among authors: zanoteli e. Arq Neuropsiquiatr. 2022 May;80(5 Suppl 1):238-248. doi: 10.1590/0004-282X-ANP-2022-S131. Arq Neuropsiquiatr. 2022. PMID: 35976321 Free PMC article. Review.
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial.
Masson R, Mazurkiewicz-Bełdzińska M, Rose K, Servais L, Xiong H, Zanoteli E, Baranello G, Bruno C, Day JW, Deconinck N, Klein A, Mercuri E, Vlodavets D, Wang Y, Dodman A, El-Khairi M, Gorni K, Jaber B, Kletzl H, Gaki E, Fontoura P, Darras BT; FIREFISH Study Group. Masson R, et al. Among authors: zanoteli e. Lancet Neurol. 2022 Dec;21(12):1110-1119. doi: 10.1016/S1474-4422(22)00339-8. Epub 2022 Oct 14. Lancet Neurol. 2022. PMID: 36244364 Clinical Trial.
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls.
Darras BT, Masson R, Mazurkiewicz-Bełdzińska M, Rose K, Xiong H, Zanoteli E, Baranello G, Bruno C, Vlodavets D, Wang Y, El-Khairi M, Gerber M, Gorni K, Khwaja O, Kletzl H, Scalco RS, Fontoura P, Servais L; FIREFISH Working Group. Darras BT, et al. Among authors: zanoteli e. N Engl J Med. 2021 Jul 29;385(5):427-435. doi: 10.1056/NEJMoa2102047. N Engl J Med. 2021. PMID: 34320287
Gene therapy in neuromuscular disorders.
Mendonça RH, Zanoteli E. Mendonça RH, et al. Among authors: zanoteli e. Arq Neuropsiquiatr. 2022 May;80(5 Suppl 1):249-256. doi: 10.1590/0004-282X-ANP-2022-S135. Arq Neuropsiquiatr. 2022. PMID: 35976325 Free PMC article. Review.
Clinical Classification of Variants in the Valosin-Containing Protein Gene Associated With Multisystem Proteinopathy.
Schiava M, Ikenaga C, Topf A, Caballero-Ávila M, Chou TF, Li S, Wang F, Daw J, Stojkovic T, Villar-Quiles R, Nishino I, Inoue M, Nishimori Y, Saito Y, Katsuno M, Noda S, Ito C, Otsuka M, Nahir S, Manousakis G, Walk D, Quinn C, Alfano L, Sahenk Z, Tasca G, Monforte M, Sabatelli M, Bisogni G, Oldfors A, Rydeliu A, Pal E, Paradas C, Velez B, De Bleecker JL, Farugia ME, Longman C, Harms MB, Ralston S, Zanoteli E, Macedo Serafim da Silva A, Sotoca J, Juntas-Morales R, Bevilacqua J, Balart M, Talbot S, Straub V, Guglieri M, Marini-Bettolo C, Diaz-Manera J, Weihl CC. Schiava M, et al. Among authors: zanoteli e. Neurol Genet. 2023 Aug 15;9(5):e200093. doi: 10.1212/NXG.0000000000200093. eCollection 2023 Oct. Neurol Genet. 2023. PMID: 37588275 Free PMC article.
Rhabdomyolysis: a genetic perspective.
Scalco RS, Gardiner AR, Pitceathly RD, Zanoteli E, Becker J, Holton JL, Houlden H, Jungbluth H, Quinlivan R. Scalco RS, et al. Among authors: zanoteli e. Orphanet J Rare Dis. 2015 May 2;10:51. doi: 10.1186/s13023-015-0264-3. Orphanet J Rare Dis. 2015. PMID: 25929793 Free PMC article. Review.
Therapeutic advances in 5q-linked spinal muscular atrophy.
Reed UC, Zanoteli E. Reed UC, et al. Among authors: zanoteli e. Arq Neuropsiquiatr. 2018 Apr;76(4):265-272. doi: 10.1590/0004-282x20180011. Arq Neuropsiquiatr. 2018. PMID: 29742241 Free article. Review.
Hypoglycemia in Patients With LAMA2-CMD.
Camelo CG, Martins Moreno CA, Artilheiro MC, Serafim Silva AM, Quadros Monteiro Fonseca AT, Mendonça de Holanda R, Reed UC, Zanoteli E. Camelo CG, et al. Among authors: zanoteli e. Pediatr Neurol. 2023 Jun;143:1-5. doi: 10.1016/j.pediatrneurol.2023.01.017. Epub 2023 Feb 7. Pediatr Neurol. 2023. PMID: 36934516
Juvenile Gerstmann-Sträussler-Scheinker Disease Mimicking Anticipation Phenomenon.
Yoshinaga Tonholo Silva T, Oliveira Marques MV, Zanoteli E, Pedroso JL, Graziani Povoas Barsottini O. Yoshinaga Tonholo Silva T, et al. Among authors: zanoteli e. Mov Disord Clin Pract. 2023 Sep 15;10(11):1700-1702. doi: 10.1002/mdc3.13878. eCollection 2023 Nov. Mov Disord Clin Pract. 2023. PMID: 37982114 No abstract available.
Gene-based therapies for neuromuscular disorders.
Zanoteli E, França MC Jr, Marques W Jr. Zanoteli E, et al. Arq Neuropsiquiatr. 2024 Jun;82(6):1-10. doi: 10.1055/s-0043-1777755. Epub 2024 Feb 7. Arq Neuropsiquiatr. 2024. PMID: 38325390 Free PMC article.
152 results